Concepedia

Publication | Open Access

Natural history and survival in stage 1 Val30Met transthyretin familial amyloid polyneuropathy

92

Citations

25

References

2018

Year

Abstract

This study provides Class III evidence that for patients with stage 1 Val30Met TTR-FAP, LTx and tafamidis increase survival.

References

YearCitations

Page 1